Accumulating evidence indicates that overconsumption of ethanol contributes in many ways to the pathogenesis of hepatic injury. Although studies indicate that taurine decreases lipogenesis, oxidative stress, and inflammatory cytokines, the protective effect of taurine against alcohol-induced liver injury is still unclear. To clarify the precise signaling involved in the beneficial effect of taurine on alcohol-induced liver injury, rats were randomly divided into four treatment groups: (1) control (Ctl), (2) alcohol (Alc), (3) Alc+taurine (Tau), and (4) Alc+silymarin (Sil). The Tau and Sil groups had lower lymphocyte infiltration and significantly lower TLR-4/MyD88 and IκB/NFκB compared to the Alc group. The inducible nitric oxide synthase (iNOS), C-reactive protein (CRP), tumor necrosis factors (TNF)-α, interleukin (IL)-6, and IL-1β were also significantly lower in the Tau and Sil groups than in the Alc group. The experimental results indicated that hepatoprotection against alcohol-induced inflammation may be mediated by decreased TLR-4/MyD88 signaling.
Get full access to this article
View all access options for this article.
References
1.
RegimbeauJM, AbdallaEK, VautheyJN, et al.: Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: Results of a multicenter study. J Surg Oncol, 2004; 85:36–41.
2.
O'SheaRS, DasarathyS, McCulloughAJ; Practice Guideline Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology: Alcoholic liver disease. Hepatology, 2010; 51:307–328.
TsukamotoH, TownerSJ, CiofaloLM, FrenchSW: Ethanol- induced liver fibrosis in rats fed high fat diet. Hepatology, 1986; 6:814–822.
7.
Tien KuoM, SavarajN: Roles of reactive oxygen species in hepatocarcinogenesis and drug resistance gene expression in liver cancers. Mol Carcinog, 2006; 45:701–709.
8.
BruckR, AeedH, AvniIY, et al.: Melatonin inhibits nuclear factor kappa B activation and oxidative stress and protects against thioacetamide induced liver damage in mice. J Hepatol, 2004; 40:86–93.
9.
SchopenRD, LangeOK: Therapy of hepatoses. Therapeutic use of silymarin. Med Welt, 1970; 15:691–698.
10.
PlattD, SchnorrB: Biochemical and electronoptic study on the possible effect of silymarin on ethanol-induced liver damage in rats. Arzneimittelforschung, 1971; 21:1206–1208.
11.
LieberCS, LeoMA, CaoQ, RenC, DeCarliLM: Silymarin retards the progression of alcohol-induced hepatic fibrosis in baboons. J Clin Gastroenterol, 2003; 37:336–339.
12.
FehérJ, LengyelG: Silymarin in the treatment of chronic liver diseases: Past and future. Orv Hetil, 2008; 149:2413–2418.
13.
HanjeAJ, FortuneB, SongM, HillD, HillD, McClainC: The use of selected nutrition supplements and complementary and alternative medicine in liver disease. Nutr Clin Pract, 2006; 21:255–272.
14.
LeeJY, JungDW, ParkHA, et al.: Effect of taurine on biliary excretion and metabolism of acetaminophen in male hamsters. Biol Pharm Bull, 2004; 27:1792–1796.
15.
BouckenoogheT, RemacleC, ReusensB: Is taurine a functional nutrient?. Curr Opin Clin Nutr Metab Care, 2006; 9:728–733.
16.
EdgarSE, KirkCA, RogersQR, MorrisJG: Taurine status in cats is not maintained by dietary cysteinesulfinic acid. J Nutr, 1998; 128:751–757.
17.
KadamSU, PrabhasankarP: Marine foods as functional ingredients in bakery and pasta products. Food Res Int, 2010; 43:1975–1980.
18.
BidriM, ChoayP: Taurine: A particular aminoacid with multiple functions. Ann Pharm Fr, 2003; 61:385–391.
19.
ChouCH, ChangYY, TzangBS, et al.: Effects of taurine on hepatic lipid metabolism and anti-inflammation in chronic alcohol-fed rats. Food Chem, 2012; 135:24–30.
20.
WuMT, TzangBS, ChangYY, et al.: Effects of Antrodia camphorata on alcohol clearance and antifibrosis in livers of rats continuously fed alcohol. J Agric Food Chem, 2011; 59:4248–4254.
21.
HsuTC, TsaiCC, ChiuCC, HsuJD, HsuJD, TzangBS: Exacerbating effects of human parvovirus B19 NS1 on liver fibrosis in NZB/W F1 mice. PLoS One, 2013; 8:e68393.
22.
HuangCY, HsuTC, KuoWW, et al.: Beneficial effects of taurine on cardiac abnormality in NZB/W F1 mice fed with a high-cholesterol diet. J Agric Food Chem, 2009; 57:8635–8642.
23.
HsuTC, ChiuCC, WangYW, TzangBS: Effects of cystamine on antioxidant activities and regulatory T cells in lupus-prone mice. J Cell Mol Med, 2013; 17:1308–1315.
24.
ChesneyRW: Taurine: Its biological role and clinical implications. Adv Pediatr, 1985; 32:1–42.
25.
HuxtableRJ: Physiological actions of taurine. Physiol Rev, 1992; 72:101–163.
GrimbleRF: Sulphur amino acids and the metabolic response to cytokines. Adv Exp Med Biol, 1994; 359:41–49.
28.
KontnyE, SzczepanskaK, KowalczewskiJ, et al.: The mechanism of taurine chloramine inhibition of cytokine (interleukin-6, interleukin-8) production by rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheum, 2000; 43:2169–2177.
29.
ChorazyM, KontnyE, MarcinkiewiczJ, MaslinskiW: Taurine chloramine modulates cytokine production by human peripheral blood mononuclear cells. Amino Acids, 2002; 23:407–413.
30.
WuG, YangJ, SunC, LuanX, ShiJ, HuJ: Effect of taurine on alcoholic liver disease in rats. Amino Acids, 2009; 36:457–464.
31.
TakedaK, KaishoT, AkiraS: Toll-like receptors. Annu Rev Immunol, 2003; 21:335–376.
32.
RohYS, SekiE: Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis. J Gastroenterol Hepatol, 2013; 28:38–42.
DarkeS, DuflouJ, TorokM, ProlovT: Characteristics, circumstances and toxicology of sudden or unnatural deaths involving very high range alcohol concentrations. Addiction, 2013; 108:1411–1417.
JensenK, GluudC: The Mallory body: Morphological, clinical and experimental studies (Part 1 of a literature survey). Hepatology, 1994; 20:1061–1077.
42.
OlivaJ, Bardag-GorceF, LinA, FrenchBA, FrenchSW: The role of cytokines in UbD promoter regulation and Mallory-Denk body-like aggresomes. Exp Mol Pathol, 2010; 89:1–8.
43.
NeumanMG: Cytokines–central factors in alcoholic liver disease. Alcohol Res Health, 2003; 27:307–316.
44.
GongP, CanaanA, WangB, et al.: The ubiquitin-like protein FAT10 mediates NF-kappaB activation. J Am Soc Nephrol, 2010; 21:316–326.
45.
ChengKC, AsakawaA, LiYX, et al.: Silymarin induces insulin resistance through an increase of phosphatase and tensin homolog in Wistar rats. PLoS One, 2014; 9:e84550.
